Literature DB >> 1367409

Improvement in the proliferative activity of human-human hybridomas at low cell density by transfection with bFGF gene.

K Iwamoto1, Y Shintani, H Sawada, K Kitano.   

Abstract

Highly purified recombinant basic fibroblast growth factor (rbFGF) and acidic FGF (aFGF) stimulated the proliferation of human-human (h-h) hybridomas to the extent of over four-fold from a low cell density such as 1 x 10(3) cells per ml in a serum-free medium in 24-well plates. The stimulatory effect of rbFGF was also observed in various lymphoid cell lines. Expecting that FGF could be an autocrine growth factor, we introduced bFGF gene into a h-h hybridoma using an expression plasmid induced by dexamethasone. The transformed cells thus obtained, HPO-75.11 bFGF-7, were able to grow well from a low inoculum density in a serum-free medium and antibody production was also increased when bFGF gene expression was induced. The transformed cells could grow at clonal density in a serum-free medium in 96-well plates, though the original cells could not. We also obtained a more practical transfectant, HPO-75.29-H74, using a high-shear stress adapted clone as the recipient and an expression plasmid having bFGF gene under the control of metallothionein-I promoter. The HPO-75.29-H74 cells were capable of growing and producing human monoclonal antibody against hepatitis B virus surface antigen from an inoculum density of 1 x 10(3) cells per ml in an agitation vessel without addition of an inducer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367409     DOI: 10.1007/bf00373026

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

1.  Improvement in the antibody productivity of human-human hybridomas by transfection with Tac gene.

Authors:  K Iwamoto; Y Shintani; R Sasada; T Honjo; K Kitano
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

2.  Potentiation of the proliferative response of human B lymphocytes to low molecular weight B cell growth factor (LMW-BCGF) by fibroblast growth factors (FGFs).

Authors:  E Genot; E Petit-Koskas; M Sensenbrenner; G Labourdette; J P Kolb
Journal:  Cell Immunol       Date:  1989-09       Impact factor: 4.868

3.  Hybridoma cultivation in defined serum-free media: growth-supporting substances. II. Insulin, other hormones, and growth factors.

Authors:  J Kovár
Journal:  Folia Biol (Praha)       Date:  1986       Impact factor: 0.906

Review 4.  Structural characterization and biological functions of fibroblast growth factor.

Authors:  D Gospodarowicz; N Ferrara; L Schweigerer; G Neufeld
Journal:  Endocr Rev       Date:  1987-05       Impact factor: 19.871

5.  Effective production of a human monoclonal antibody against tetanus toxoid by selection of high productivity clones of a heterohybridoma.

Authors:  K Kitano; K Iwamoto; Y Shintani; S Akiyama
Journal:  J Immunol Methods       Date:  1988-04-22       Impact factor: 2.303

6.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.

Authors:  H Wakasugi; L Rimsky; Y Mahe; A M Kamel; D Fradelizi; T Tursz; J Bertoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

8.  Effect of substrata and fibroblast growth factor on the proliferation in vitro of bovine aortic endothelial cells.

Authors:  D Gospodarowicz; G M Lui
Journal:  J Cell Physiol       Date:  1981-10       Impact factor: 6.384

9.  Potentiation of hybridoma production by the use of mouse fibroblast conditioned media.

Authors:  K Z Walker; J Gibson; S M Axiak; R L Prentice
Journal:  J Immunol Methods       Date:  1986-04-03       Impact factor: 2.303

10.  Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA.

Authors:  R Sasada; T Kurokawa; M Iwane; K Igarashi
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.